查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1376012

精准医疗市场规模、份额和趋势分析报告：2023-2030 年按应用、最终用途、地区和细分市场分類的趋势

Precision Medicine Market Size, Share & Trends Analysis Report By Application (Diagnostics (Genetic Tests, Esoteric Tests)), Therapeutics (Pharmaceuticals, Medical Devices), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 145 Pages | 商品交期: 2-10个工作天内

价格

精准医疗市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球精准医疗市场规模将达到1,607.8亿美元，2023年至2030年年复合成长率为10.7%。

引入具有成本效益的基因组和分子生物学检测方法、癌症和罕见疾病盛行率的增加以及精准医疗中巨量资料的使用增加等趋势是推动市场成长的关键因素。

人类基因计划引入了令人兴奋的最尖端科技，例如全基因组序列测定和靶向序列测定。研究人员利用这些技术来研究基因组并创造治疗各种疾病的个体化疗法。如今，世界各地肿瘤学、免疫学和神经学等领域的疾病盛行率正在迅速增加。

研究人员、医疗保健专业人员以及大型製药和生物技术公司正在共同努力，为患者健康发现新的治疗方法选择。许多治疗方法和药物目前正在进行临床试验以治疗各种类型的癌症。此外，研究人员有兴趣在癌症以外的疾病领域开发精准医学和诊断方法。

除了治疗之外，诊断领域近年来也经历了快速成长。次世代定序（NGS）、生物标记、伴随诊断和深奥测试的使用有可能改变和影响药物处方模式。个体化药物很可能在未来20年内取得巨大成功，并有能力治疗和治癒少数以前不可能的疾病。

政府和法规机构的参与对该行业的发展发挥着至关重要的作用。 2015年，时美国政府宣布推出精准医疗计画。隔年，中国启动了中国精准医疗计画。这是一项为期15年的计划，旨在将国家打造成精准治疗发展的领导者。

目前，生物技术和製药公司改进产品线中超过 40% 的药物都含有生物标记。该简报还建议，一些生物製药公司在过去年度中已经建立了合作和合资企业，预计在未来年度将继续下去。因此，诊断和治疗精准医学市场潜力巨大，并正在迅速转变为患者照护的基本领域。

精准医疗市场报告亮点

  • 基因序列测定、生物标记、巨量资料分析和伴随诊断等技术预计将在未来年度推动这一市场。
  • 从最终用途来看，临床实验室将在 2022 年占据主导市场。同时，居家医疗检测领域因其速度、效率和便利性而正在快速发展。
  • 依适应症领域划分，2022年癌症治疗精准药物占最大市场占有率。然而，研究人员正在将重点转向开发针对非肿瘤疾病的精准药物。因此，免疫、遗传和罕见疾病越来越受到关注。
  • 北美市场目前占据最大份额，预计在预测期内将进一步成长。市场主要受到政府支持性政策和措施以及市场参与者的强大推动。亚太地区预计将成为该市场成长最快的地区。

目录

第1章调查方法和范围

第2章执行摘要

第3章精准医疗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 精准医疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章精准医疗：应用预估与趋势分析

  • 精准医疗市场：要点
  • 精准医疗市场：2022 年和 2030 年趋势和市场占有率分析
  • 诊断
    • 2018年至2030年诊断市场估计与预测
    • 基因检测
    • 直接面向消费者的测试
    • 困难的考验
    • 其他的
  • 治疗
    • 2018年至2030年治疗药物市场估计与预测
    • 药品
    • 医疗设备
    • 其他的

第5章精准医疗：最终用途估计与趋势分析

  • 精准医疗市场：要点
  • 精准医疗市场：2022 年和 2030 年趋势和市场占有率分析
  • 居家护理
  • 医院
  • 临床实验室
  • 其他的

第6章精准医疗市场：区域估算与趋势分析

  • 区域展望
  • 按地区分類的精准医疗市场：主要市场亮点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • F. Hoffmann-La Roche Ltd.-Foundation Medicine
    • Siemens Healthineers
    • Janssen Pharmaceuticals
    • Illumina
    • Quest Diagnostics Incorporated.
    • 23andMe, Inc.
    • NeoDiagnostix, Inc.,
    • IBM Watson
    • Myriad Genetics Inc.
    • Medtronic
    • GE Healthcare
    • Abbott Laboratories
    • Dako A/S
    • Biogen
    • Precision Biologics Incorporated
    • Qiagen Incorporated
Product Code: GVR-2-68038-612-7

Precision Medicine Market Growth & Trends:

The global precision medicine market size is expected to reach USD 160.78 billion by 2030 growing at a CAGR of 10.7% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Involvement of government and regulatory bodies has played a very important role in the growth of this field. In 2015, the then U.S. government announced the launch of the Precision Medicine Initiative. The following year, China launched the China Precision Medicine Initiative, which is a 15-year project that aims to build the country as a leader in development of precision therapies.

At present, more than 40% of the medications in biotech and pharmaceutical companies' improvement pipeline incorporate biomarkers. The overview likewise recommended that some biopharmaceutical organizations have collaborated and joint their ventures in the past five years and are expected to continue doing so in the coming years. The diagnostic and therapeutic precision medicine market thus holds immense potential and is quickly turning into a fundamental segment of patient care.

Precision Medicine Market Report Highlights:

  • Technologies such as gene sequencing, biomarkers, big data analytics, and companion diagnostics are anticipated to drive this market in the coming years
  • By end use, clinical labs held the dominant share in the market in 2022. The home care testing segment, on the other hand, has been witnessing rapid growth due to its speed, efficiency, and convenience
  • On the basis of indication area, therapeutic precision medicines for oncology held the largest market share in 2022. However, there has been a change in focus of researchers toward the development of precision medicines for non-oncologic diseases. This has resulted in greater focus on immunological, genetic, and rare diseases
  • The North America market currently holds the largest share and is expected to grow further during the forecast period. The market is primarily driven by supportive policies and initiatives by the government and strong presence of market players. Asia Pacific is expected to emerge as the fastest growing region in this market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Precision Medicine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Precision Medicine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Precision Medicine: Application Estimates & Trend Analysis

  • 4.1. Precision Medicine Market: Key Takeaways
  • 4.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Diagnostics
    • 4.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Genetic tests
      • 4.3.2.1. Genetic tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Direct to consumer tests
      • 4.3.3.1. Direct to consumer tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Esoteric tests
      • 4.3.4.1. Esoteric tests market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Others
      • 4.3.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Therapeutics
    • 4.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Pharmaceuticals
      • 4.4.2.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Oncology
      • 4.4.2.2.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Respiratory diseases
      • 4.4.2.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.4. Skin diseases
      • 4.4.2.4.1. Skin diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.5. CNS disorders
      • 4.4.2.5.1. CNS disorders market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.6. Immunology
      • 4.4.2.6.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.7. Genetic diseases
      • 4.4.2.7.1. Genetic diseases market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.8. Others
      • 4.4.2.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Medical Devices
      • 4.4.3.1. Medical Devices market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Precision Medicine: End Use Estimates & Trend Analysis

  • 5.1. Precision Medicine Market: Key Takeaways
  • 5.2. Precision Medicine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Home Care
    • 5.3.1. Home care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Clinical Laboratories
    • 5.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Precision Medicine Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Precision Medicine Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. F. Hoffmann-La Roche Ltd.-Foundation Medicine
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Siemens Healthineers
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Janssen Pharmaceuticals
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Illumina
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Quest Diagnostics Incorporated.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. 23andMe, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. NeoDiagnostix, Inc.,
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. IBM Watson
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Myriad Genetics Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Medtronic
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. GE Healthcare
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Abbott Laboratories
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Dako A/S
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Biogen
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives
    • 7.2.15. Precision Biologics Incorporated
      • 7.2.15.1. Company overview
      • 7.2.15.2. Financial performance
      • 7.2.15.3. Product benchmarking
      • 7.2.15.4. Strategic initiatives
    • 7.2.16. Qiagen Incorporated
      • 7.2.16.1. Company overview
      • 7.2.16.2. Financial performance
      • 7.2.16.3. Product benchmarking
      • 7.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 17 France precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 31 China precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 32 China precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 36 India precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Australia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 38 Australia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 42 South Korea precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa precision medicine market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE precision medicine market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait precision medicine market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait precision medicine market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Precision medicine: Market outlook
  • Fig. 9 Precision medicine: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Precision medicine market driver impact
  • Fig. 15 Precision medicine market restraint impact
  • Fig. 16 Precision medicine market strategic initiatives analysis
  • Fig. 17 Precision medicine market: Application movement analysis
  • Fig. 18 Precision medicine market: Application outlook and key takeaways
  • Fig. 19 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Genetic tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Direct to consumer tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Esoteric tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Skin diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 CNS disorders market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Genetic diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Medical devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Precision medicine market: End-use movement analysis
  • Fig. 36 Precision medicine market: End-use outlook and key takeaways
  • Fig. 37 Home care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global precision medicine market: Regional movement analysis
  • Fig. 42 Global precision medicine market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)